SHEFFIELD LAKE –Thomas “Surf” Surface, 59, passed away Sunday December 4, 2016 due to complications from pneumonia. He was born on September 16, 1957. He attended Brookside High School and was a ...

As of February 10, 2023, the average one-year price target for Surface Oncology is $5.51. The forecasts range from a low of $3.03 to a high of $6.30. The average price target represents an increase of ...

As of January 30, 2023, the average one-year price target for Surface Oncology is $5.51. The forecasts range from a low of $3.03 to a high of $6.30. The average price target represents an increase of ...

Peak Metrology, automated metrology equipment designer and manufacturer, and Digital Surf, editor of analysis software solutions for profilometry, microscopy and spectroscopy, have announced the ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Surface Oncology, Inc. (NASDAQ: SURF) to Coherus BioSciences, Inc. is fair to Surface ...

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Surface Oncology ...

The market expects Surface Oncology, Inc. (SURF) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2020. This widely-known ...

Coherus BioSciences Inc CHRS has agreed to acquire Surface Oncology Inc SURF, a clinical-stage immuno-oncology (I-O) company developing next-generation immunotherapies that target the tumor ...